Cargando…

Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach

Detalles Bibliográficos
Autores principales: Hu, Xiao, Liu, Xikui, Morgan, Rodney, Moisan, Jacques, Hao, Ling-Yang, Wang, Yahong, Sanchez, Brian, Lesch, Charles, Bousley, Dick, Taylor, Clark, Aicher, Thomas, Toogood, Peter, Zou, Weiping, Glick, Gary, Carter, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292404/
http://dx.doi.org/10.1186/2051-1426-2-S3-P194
_version_ 1782352478867554304
author Hu, Xiao
Liu, Xikui
Morgan, Rodney
Moisan, Jacques
Hao, Ling-Yang
Wang, Yahong
Sanchez, Brian
Lesch, Charles
Bousley, Dick
Taylor, Clark
Aicher, Thomas
Toogood, Peter
Zou, Weiping
Glick, Gary
Carter, Laura
author_facet Hu, Xiao
Liu, Xikui
Morgan, Rodney
Moisan, Jacques
Hao, Ling-Yang
Wang, Yahong
Sanchez, Brian
Lesch, Charles
Bousley, Dick
Taylor, Clark
Aicher, Thomas
Toogood, Peter
Zou, Weiping
Glick, Gary
Carter, Laura
author_sort Hu, Xiao
collection PubMed
description
format Online
Article
Text
id pubmed-4292404
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42924042015-01-15 Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach Hu, Xiao Liu, Xikui Morgan, Rodney Moisan, Jacques Hao, Ling-Yang Wang, Yahong Sanchez, Brian Lesch, Charles Bousley, Dick Taylor, Clark Aicher, Thomas Toogood, Peter Zou, Weiping Glick, Gary Carter, Laura J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292404/ http://dx.doi.org/10.1186/2051-1426-2-S3-P194 Text en Copyright © 2014 Hu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Hu, Xiao
Liu, Xikui
Morgan, Rodney
Moisan, Jacques
Hao, Ling-Yang
Wang, Yahong
Sanchez, Brian
Lesch, Charles
Bousley, Dick
Taylor, Clark
Aicher, Thomas
Toogood, Peter
Zou, Weiping
Glick, Gary
Carter, Laura
Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
title Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
title_full Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
title_fullStr Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
title_full_unstemmed Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
title_short Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
title_sort novel synthetic rorγ agonist compounds as a potential anti-tumor therapeutic approach
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292404/
http://dx.doi.org/10.1186/2051-1426-2-S3-P194
work_keys_str_mv AT huxiao novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT liuxikui novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT morganrodney novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT moisanjacques novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT haolingyang novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT wangyahong novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT sanchezbrian novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT leschcharles novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT bousleydick novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT taylorclark novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT aicherthomas novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT toogoodpeter novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT zouweiping novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT glickgary novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach
AT carterlaura novelsyntheticrorgagonistcompoundsasapotentialantitumortherapeuticapproach